MedPath

Ayurvedic treatment of insufficient lactatio

Phase 2
Conditions
Health Condition 1: O998- Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
Registration Number
CTRI/2019/08/020579
Lead Sponsor
ICMR
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Mother

1 Exclusively breast feeding mothers with complaint of insufficient lactation.

2 Age between 20-40 years

3 Full Term Delivery � 37 weeks

4 Primi or multipara with singleton baby

5 Willing and able to give written consent

Baby

6 Baby with birth weight � 2.5 kg who has not attained actual birth weight by 14 days

7 After 14 days of age weight gain less than 20gm/day from 15th day of birth to 3rd month of birth

8 Urination less than 6 times/day

Exclusion Criteria

1 Mothers with active herpes breast/breast abscess/retracted nipple/severely cracked nipples, having HbsAg+ve, HIV+ve, Tuberculosis, Chronic medical conditions.

2 Mother is taking medicine like Pseudoephedrine, methargin, bromocriptine, any other galactogogues (Allopathic/Ayurvedic)

3 Mother having Malignancy and Diabetes melitus

4 Neonate with congenital malformations which may interfere in breast feeding or requiring surgery in first six months of life.

5 Baby with acute respiratory infection, pneumonia, urinary tract infection, infective diarrhoea, meningitis at the time of recruitment

Subjects will be enrolled in to the study after satisfying the inclusion/exclusion criteria. Each subject will be assigned a unique subject number, which identifies the individual.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1 Proportion of mothers complaining of insufficient lactation at the end of the study period. <br/ ><br>2 Proportion of babies with a Weight gain of 20gms/day in those who were exclusively breast feed.Timepoint: Time frame: Baseline and every two weeks up to the end of 14weeks
Secondary Outcome Measures
NameTimeMethod
1. Proportion of babies crying even after breast feeding. <br/ ><br>2. Clinical safety of the investigational product assessed through LFT & KFT. <br/ ><br>3. No. of participants reporting any ADR/AE.Timepoint: Time frame: 1. Baseline and every two weeks up to the end of 14 weeks. <br/ ><br>2. Time frame: Baseline and at the end of the treatment <br/ ><br>3. Time frame: Baseline and every two weeks up to the end of 14 weeks
© Copyright 2025. All Rights Reserved by MedPath